bluebird bio to sell Durham facility for $110M to National Resilience, Inc.
DURHAM – For the purpose of forming a strategic alliance to accelerate research, development, and delivery of cell therapies, bluebird bio plans to sell its 125,000 square foot facility in Durham to National Resilience, Inc., for $110 million, according to a statement from the company. The new owner of the...
Read More
